Engineered microalgal extracellular vesicles for efficient doxorubicin delivery and improved therapeutic efficacy in breast cancer

Extracellular vesicles (EVs) have emerged as versatile and biocompatible nanocarriers for drug delivery, offering significant advantages over synthetic nanoparticles, which often suffer from rapid clearance, immunogenicity, and limited clinical translation. In this study, we introduce nanoalgosomes,...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Giorgia Adamo, Sabrina Picciotto, Pamela Santonicola, Paola Gargano, Estella Rao, Angela Paterna, Samuele Raccosta, Giulia Smeraldi, Carolina Paganini, Daniele P. Romancino, Monica Salamone, Claudio Russo, Paolo Arosio, Elia Di Schiavi, Mauro Manno, Antonella Bongiovanni
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2026-04-01
Rangatū:	Materials Today Bio
Ngā marau:	Extracellular vesicles Nanoalgosomes Doxorubicin Drug delivery system Therapeutics Chemotherapeutics
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2590006426000347
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!